DE69517331D1 - Verfahren und verbindungen zum screening von presynaptischen calcium kanal inhibitoren - Google Patents

Verfahren und verbindungen zum screening von presynaptischen calcium kanal inhibitoren

Info

Publication number
DE69517331D1
DE69517331D1 DE69517331T DE69517331T DE69517331D1 DE 69517331 D1 DE69517331 D1 DE 69517331D1 DE 69517331 T DE69517331 T DE 69517331T DE 69517331 T DE69517331 T DE 69517331T DE 69517331 D1 DE69517331 D1 DE 69517331D1
Authority
DE
Germany
Prior art keywords
screening
connections
calcium channel
presynaptic calcium
channel inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69517331T
Other languages
English (en)
Other versions
DE69517331T2 (de
Inventor
A Catterall
Zu-Hang Sheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Application granted granted Critical
Publication of DE69517331D1 publication Critical patent/DE69517331D1/de
Publication of DE69517331T2 publication Critical patent/DE69517331T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
DE69517331T 1994-11-10 1995-11-09 Verfahren und verbindungen zum screening von presynaptischen calcium kanal inhibitoren Expired - Fee Related DE69517331T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/337,602 US5623051A (en) 1994-11-10 1994-11-10 Methods and compositions for screening for presynaptic calcium channel blockers
PCT/US1995/014776 WO1996015149A2 (en) 1994-11-10 1995-11-09 Methods and compositions for screening for presynaptic calcium channel blockers

Publications (2)

Publication Number Publication Date
DE69517331D1 true DE69517331D1 (de) 2000-07-06
DE69517331T2 DE69517331T2 (de) 2001-01-04

Family

ID=23321213

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69517331T Expired - Fee Related DE69517331T2 (de) 1994-11-10 1995-11-09 Verfahren und verbindungen zum screening von presynaptischen calcium kanal inhibitoren

Country Status (8)

Country Link
US (2) US5623051A (de)
EP (1) EP0791013B1 (de)
JP (1) JPH10509945A (de)
AT (1) ATE193542T1 (de)
AU (1) AU4282396A (de)
CA (1) CA2206110A1 (de)
DE (1) DE69517331T2 (de)
WO (1) WO1996015149A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5638972A (en) * 1988-06-17 1997-06-17 Druitt; Rodney Malcolm Linerless closure for carbonated beverage container
US5620850A (en) 1994-09-26 1997-04-15 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
US5623051A (en) * 1994-11-10 1997-04-22 University Of Washington Methods and compositions for screening for presynaptic calcium channel blockers
AU1084997A (en) * 1995-12-01 1997-06-19 Board Of Trustees Of The Leland Stanford Junior University Calcium channel modulator compositions and methods
US5939540A (en) * 1996-10-07 1999-08-17 President And Fellows Of Harvard College Platelet secretory transport protein
WO1998028419A2 (en) * 1996-12-20 1998-07-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulation of vesicular release
AU6440798A (en) * 1997-02-26 1998-09-18 Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulation of vesicular release
CA2295098A1 (en) * 1997-06-30 1999-01-07 Allergan Sales, Inc. Calcium blockers to treat proliferative vitreoretinopathy
US20050009884A1 (en) * 1997-06-30 2005-01-13 Dreyer Evan B. Calcium blockers to treat proliferative retinal diseases
AU8571598A (en) * 1997-07-17 1999-02-10 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
US6492375B2 (en) 1998-06-30 2002-12-10 Neuromed Technologies, Inc. Partially saturated calcium channel blockers
US6943168B2 (en) * 1998-06-30 2005-09-13 Neuromed Technologies Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6951862B2 (en) * 1998-06-30 2005-10-04 Neuromed Technologies, Inc. Calcium channel blockers comprising two benzhydril moieties
US7186726B2 (en) * 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers
US20060084660A1 (en) * 1998-06-30 2006-04-20 Neuromed Technologies Inc. Calcium channel blockers comprising two benzhydril moieties
US20040266784A1 (en) * 1998-06-30 2004-12-30 Snutch Terrance P. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6387897B1 (en) 1998-06-30 2002-05-14 Neuromed Technologies, Inc. Preferentially substituted calcium channel blockers
US6011035A (en) 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
US6310059B1 (en) 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
CA2332309A1 (en) * 1998-07-02 2000-01-13 Incyte Pharmaceuticals, Inc. Neurotransmission associated proteins
US6686147B1 (en) 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
AU7896700A (en) * 1999-10-13 2001-04-23 University Of British Columbia, The Methods to identify compounds that modulate neuronal activity
US6824669B1 (en) 2000-02-17 2004-11-30 Motorola, Inc. Protein and peptide sensors using electrical detection methods
US20030195707A1 (en) * 2000-05-25 2003-10-16 Schork Nicholas J Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US7049084B2 (en) * 2001-05-30 2006-05-23 Ortho-Mcneil Pharmaceutical, Inc. Neuroblastoma cell lines expressing the α2δ subunit of calcium channels and methods therefore
US20030092039A1 (en) * 2001-08-01 2003-05-15 Third Wave Technologies, Inc. Screening nutraceuticals
JP2005511012A (ja) * 2001-08-10 2005-04-28 セローノ ジェネティクス インスティテュート ソシエテ アノニム ヒトｃＤＮＡおよびタンパク質およびその使用
CA2527159A1 (en) * 2003-05-30 2004-12-09 Neuromed Technologies, Inc. 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
US20050227999A1 (en) * 2004-04-09 2005-10-13 Neuromed Technologies Inc. Diarylamine derivatives as calcium channel blockers
CA2651811A1 (en) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
BR112013022788A2 (pt) 2011-03-08 2016-12-06 Zalicus Pharmaceuticals Ltd "composição farmacêutica compreendendo uma dispersão sólida de 1-(4-benzidrilpiperazin-1-il)-3,3-difenilpropan-1-ona"
CN106414504B (zh) * 2014-04-04 2020-12-18 马尔科·费利焦尼 用于治疗由谷氨酸兴奋性毒性引起的疾病的细胞可渗透肽系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341170C (en) * 1988-04-04 2001-01-16 Steven B. Ellis Calcium channel compositions and methods
US5386025A (en) * 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
DE69230938T2 (de) * 1991-08-15 2000-10-12 Merck & Co.,Inc. Menschliche kalziumkanäle und verwendungen davon
CA2151741C (en) * 1991-12-30 2001-12-11 Alan Justice Methods of producing analgesia and enhancing opiate analgesia
US5623051A (en) * 1994-11-10 1997-04-22 University Of Washington Methods and compositions for screening for presynaptic calcium channel blockers

Also Published As

Publication number Publication date
US6090631A (en) 2000-07-18
ATE193542T1 (de) 2000-06-15
JPH10509945A (ja) 1998-09-29
WO1996015149A3 (en) 1996-08-22
WO1996015149A2 (en) 1996-05-23
AU4282396A (en) 1996-06-06
EP0791013A2 (de) 1997-08-27
DE69517331T2 (de) 2001-01-04
CA2206110A1 (en) 1996-05-23
EP0791013B1 (de) 2000-05-31
US5623051A (en) 1997-04-22

Similar Documents

Publication Publication Date Title
DE69517331D1 (de) Verfahren und verbindungen zum screening von presynaptischen calcium kanal inhibitoren
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE69941043D1 (de) Verfahren und Gerät zum Erzeugen von Wasserzeichen für Datensätze
DK0906333T3 (da) Substrater og inhibitorer for proteolytiske enzymer
DE69710077D1 (de) Verfahren zur erkennung von verbindungen, die die interaktion von rna und rna-bindeproteinen beeinflussen
DE69520445D1 (de) System und verfahren zum sterilen verpacken von getränken
DE69837693D1 (de) Verfahren und System zum Editieren von Bildern
DK1137941T4 (da) Protein-scaffolds til antistof-mimetika og andre bindingsproteiner
DE69635347D1 (de) Verfahren und system zum wiedergeben und kombinieren von bildern
DE59901551D1 (de) Spannsystem und -verfahren zum spannen von werkstücken
DE69809726D1 (de) Substituierte analoge von indol-3-carbinol und von diindolmethan als antiestrogene
DE50111437D1 (de) Verfahren zum einbringen von zuschlagstoffen (additiven)
DE59604171D1 (de) Verfahren und verbindungen zur magnetorelaxometrischen detektion von analyten und deren verwendung
DE69637190D1 (de) Verfahren zum Abdichten von Fugen mit feuchthärtenden Organosiloxanzusammensetzungen
DE59502334D1 (de) Verfahren zum zerkleinern von hochmolekularen strukturen
DE69828682D1 (de) Nanomolare, non-peptidische inhibitoren von cathepsin d
ATE269529T1 (de) Verfahren zur behandlung von abgasen in der stahlindustrie
DE69905273D1 (de) Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen
DE69719407D1 (de) Verfahren zum Abkühlen von Stahlrohren
DE10003866B8 (de) Zusammensetzungen enthaltend stabilisierte Metallocen-Polyolefine, sowie Verfahren zum Stabilisieren von Metallocen-Polyolefinen
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69916795D1 (de) Verfahren zur speicherung und zum betrieb von informationseinheiten in einem sicherheitsmodul, und zugehöriges sicherheitsmodul
DE69835376D1 (de) Verfahren zum auffinden von verbindungen zur vorbeugung von infektion oder pathogenizität
ATE194360T1 (de) Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen
DE69719509D1 (de) Verfahren zum befestigen von auskleidungen in behältern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee